Howard Kynaston

11.6k total citations · 1 hit paper
111 papers, 4.0k citations indexed

About

Howard Kynaston is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Howard Kynaston has authored 111 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 37 papers in Surgery and 26 papers in Molecular Biology. Recurrent topics in Howard Kynaston's work include Prostate Cancer Treatment and Research (36 papers), Bladder and Urothelial Cancer Treatments (22 papers) and Prostate Cancer Diagnosis and Treatment (21 papers). Howard Kynaston is often cited by papers focused on Prostate Cancer Treatment and Research (36 papers), Bladder and Urothelial Cancer Treatments (22 papers) and Prostate Cancer Diagnosis and Treatment (21 papers). Howard Kynaston collaborates with scholars based in United Kingdom, United States and Palestinian Territory. Howard Kynaston's co-authors include Malcolm D. Mason, Wen G. Jiang, Timothy J Wilt, J.B. Court, Lin Ye, Bernadette Coles, M. Shelley, Andrew J. Sanders, Mike D. Shelley and Malcolm Mason and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Howard Kynaston

108 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes

2014 356 citations Jason Webber, Lisa K. Spary et al. Oncogene profile →

Peers

Countries citing papers authored by Howard Kynaston

Since Specialization

Citations

This map shows the geographic impact of Howard Kynaston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Kynaston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Kynaston more than expected).

Fields of papers citing papers by Howard Kynaston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Kynaston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Kynaston. The network helps show where Howard Kynaston may publish in the future.

Co-authorship network of co-authors of Howard Kynaston

This figure shows the co-authorship network connecting the top 25 collaborators of Howard Kynaston. A scholar is included among the top collaborators of Howard Kynaston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard Kynaston. Howard Kynaston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer 2024 ·Cells ·(unknown), (unknown), Nicholas Bullock, Kathryn Gilroy, (unknown), Radhika A. Patel, (unknown), Valérie S. Méniel, Gillian Seaton, Howard Kynaston, Richard Clarkson, Toby J. Phesse, Peter S. Nelson, Michael C. Haffner, John Staffurth, Helen Pearson	1
2	Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047) 2024 ·European Urology ·Chris Parker, Noel W. Clarke, Adrian Cook, René Horsleben Petersen, Charles Catton, William Cross, Howard Kynaston, Raj Persad, Fred Saad, John Logue, Heather Payne, Claire Amos, L. Bower, Rakesh Raman, Ian Sayers, Jane Worlding, Wendy R. Parulekar, Mahesh Parmar, Matthew R. Sydes	5
3	Perception of urinary biomarker tests among patients referred with suspected urological malignancy 2023 ·SHILAP Revista de lepidopterología ·Nicholas Bullock, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michael A. Davies, (unknown), Krishna Narahari, Ian Weeks, Howard Kynaston	2
4	Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT Trial 2023 ·International Journal of Radiation OncologyBiologyPhysics ·René Horsleben Petersen, Adrian Cook, Matthew R. Sydes, Noel W. Clarke, William Cross, Howard Kynaston, John Logue, (unknown), Heather Payne, Mahesh Parmar, Wendy R. Parulekar, Raj Persad, Fred Saad, (unknown), Christopher Parker, Charles Catton	8
5	Stroma‐derived extracellular vesicle mRNA signatures inform histological nature of prostate cancer 2021 ·Journal of Extracellular Vesicles ·(unknown), Peter Giles, (unknown), (unknown), Lisa K. Spary, Howard Kynaston, Mark Gurney, Juan Manuel Falcón‐Pérez, Félix Royo, Zsuzsanna Tabi, Dimitris Parthimos, Rachel J. Errington, Aled Clayton, Jason Webber	21
6	Utilisation of the STEAP protein family in a diagnostic setting may provide a more comprehensive prognosis of prostate cancer 2019 ·PLoS ONE ·Stephanie Burnell, (unknown), (unknown), Owen Bodger, Howard Kynaston, Claire Morgan, Shareen H. Doak	32
7	Knockdown of WAVE3 impairs HGF induced migration and invasion of prostate cancer cells 2015 ·Cancer Cell International ·(unknown), Lin Ye, Ping‐Hui Sun, Howard Kynaston, Wen G. Jiang	10
8	Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes breakdown → 2014 ·Oncogene ·Jason Webber, Lisa K. Spary, Andrew J. Sanders, R Chowdhury, Wen G. Jiang, Robert Steadman, Jennifer M. Wymant, Arwyn T. Jones, Howard Kynaston, Malcolm D. Mason, Zsuzsanna Tabi, Aled Clayton	356
9	Management of lower urinary tract symptoms in men 2013 ·British Journal of Hospital Medicine ·(unknown), (unknown), (unknown), Howard Kynaston	4
10	Putative prognostic epithelial-to-mesenchymal transition biomarkers for aggressive prostate cancer 2013 ·Experimental and Molecular Pathology ·Helen Whiteland, (unknown), (unknown), C. A. Davies, Claire Morgan, Howard Kynaston, Pradeep Bose, Neil Fenn, Paul D. Lewis, Owen Bodger, S A Jenkins, Shareen H. Doak	27
11	Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer 2011 ·Journal of Translational Medicine ·Richard J. Ablin, Howard Kynaston, Malcolm D. Mason, Wen G. Jiang	7
12	The aberrant expression of bone morphogenetic protein 12 (BMP-12) in human breast cancer and its potential prognostic value 2009 ·ORCA Online Research @Cardiff (Cardiff University) ·(unknown), (unknown), Callum Parr, Anthony Douglas-Jones, Howard Kynaston, Robert E. Mansel, (unknown)	3
13	An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer 2008 ·European Journal of Cancer ·George van Andel, Andrew Bottomley, Sophie D. Fosså, Fabio Efficace, Corneel Coens, S. Guérif, Howard Kynaston, Paolo Gontero, George N. Thalmann, A. Akdaş, Sven D’haese, Neil K. Aaronson	368
14	Expression of the prostate type transglutaminase (TGase-4) in clinical prostate cancer 2007 ·Cancer Research ·Wen G. Jiang, Richard J. Ablin, Howard Kynaston, Malcolm D. Mason	2
15	Com-1/p8 acts as a putative tumour suppressor in prostate cancer 2006 ·International Journal of Molecular Medicine ·Wen G. Jiang, Gaynor Davies, Tracey A. Martin, Howard Kynaston, Malcolm Mason, Øystein Fodstad	40
16	Venous thromboembolic prophylaxis for transurethral prostatectomy: practice among British urologists 2002 ·Journal of the Royal Society of Medicine ·(unknown), P. Collins, Howard Kynaston, B. J. JENKINS	6
17	Isolated vesical endometriosis in the absence of previous surgery 2002 ·Journal of Obstetrics and Gynaecology ·Inge M Thijs, P.S. Bhal, Richard A. Shaw, Howard Kynaston	1
18	A systematic review of intravesical bacillus Calmette‐Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer 2001 ·British Journal of Urology ·M. Shelley, Howard Kynaston, J.B. Court, Timothy J Wilt, Bernadette Coles, (unknown), Malcolm D. Mason	207
19	Effects of octreotide on liver regeneration and tumour growth in the regenerating liver 1997 ·Journal of Gastroenterology and Hepatology ·Nathan Davies, John T. Yates, Howard Kynaston, (unknown), S. Jenkins	16
20	Gangrenous cystitis in a paraplegic patient. Case report 1994 ·Spinal Cord ·(unknown), Stephen Brough, Howard Kynaston, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact